Answer
Trixeo Aerosphere is indicated for maintenance treatment of adults with moderate to severe COPD inadequately treated by an inhaled corticosteroid plus a long-acting beta2-agonist, or a long-acting beta2-agonist plus a long-acting muscarinic antagonist.
Sources for this answer
- Trixeo Aerosphere 5 micrograms/7.2 micrograms/160 micrograms pressurised inhalation, suspensionAstraZeneca UK Limited · emc · SmPC §4.1 Therapeutic Indications · Version 6Document updated
Sources checked